TipRanks on MSN

Gain Therapeutics Advances Parkinson’s Treatment with GT-02287 Study

Gain Therapeutics, Inc. (($GANX)) announced an update on their ongoing clinical study. Gain Therapeutics, Inc. is conducting a clinical study ...
Pulmonology Advisor

Intranasal Adrenaline Offers Viable, Needle-Free Option for Anaphylaxis

Intranasal adrenaline represents a viable, needle-free alternative treatment for anaphylaxis, with comparable pharmacokinetics.
Healio

Some needs unmet in secondary CVD prevention despite aspirin use; new agent may have role

Please provide your email address to receive an email when new articles are posted on . Aspirin is the foundational treatment for secondary prevention of cardiac events and the standard therapy I have ...
Raleigh News & Observer

Aspire Biopharma Holdings, Inc., Announces Phase 1 Clinical Trial Initiation of its Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation

Trial designed to evaluate safety, pharmacokinetics and pharmacodynamics, of Aspire's sublingual aspirin product Aspire anticipates releasing initial clinical data from trial at the end of the second ...
Nasdaq

Aquestive Therapeutics Reports Positive Topline Data from Part 2 of EPIPHAST Trial Evaluating AQST-109 Epinephrine Oral Film

WARREN, N.J., April 12, 2022 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company advancing medicines to solve patients’ problems with current standards of care ...